TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from iX Biopharma Ltd. ( (SG:42C) ).
iX Biopharma Ltd. held an Extraordinary General Meeting (EGM) on March 10, 2025, chaired by Mr. Eddy Lee Yip Hang. The meeting included the Board of Directors and shareholders, with voting conducted by poll. The meeting proceeded without any questions from shareholders, and all motions were proposed by the Chairman.
More about iX Biopharma Ltd.
iX Biopharma Ltd. is a company incorporated in Singapore, operating within the biopharmaceutical industry. The company focuses on developing and commercializing innovative therapies and products, leveraging its proprietary sublingual drug delivery technology.
YTD Price Performance: 5.00%
Average Trading Volume: 298,678
Technical Sentiment Signal: Buy
Current Market Cap: S$18.59M
See more data about 42C stock on TipRanks’ Stock Analysis page.